John W Watson - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|December 3, 2021

Inventory Control Methods in a Long-Term Care Pharmacy: Comparisons and Time-Series AnalysesJohn W Watson, Nina Moliver, Kenneth Gossett

Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 14, 2003

P-glycoprotein limits the brain penetration of nonsedating but not sedating H1-antagonistsCuiping Chen, Elizabeth Hanson, John W Watson, et al.

Pharmacology|October 10, 2002

Anti-emetic activity of the novel nonpeptide tachykinin NK1 receptor antagonist ezlopitant (CJ-11,974) against acute and delayed cisplatin-induced emesis in the ferretMegumi Tsuchiya, Yoshiko Fujiwara, Yoshihito Kanai, et al.

Journal of Medicinal Chemistry|January 19, 2007

SAR of a series of 5,6-dihydro-(9H)-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-alpha]pyridines as potent inhibitors of human eosinophil phosphodiesteraseAllen J Duplantier, Elizabeth L Bachert, John B Cheng, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|December 3, 2021

Inventory Control Methods in a Long-Term Care Pharmacy: Comparisons and Time-Series AnalysesJohn W Watson, Nina Moliver, Kenneth Gossett

Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 14, 2003

P-glycoprotein limits the brain penetration of nonsedating but not sedating H1-antagonistsCuiping Chen, Elizabeth Hanson, John W Watson, et al.

Pharmacology|October 10, 2002

Anti-emetic activity of the novel nonpeptide tachykinin NK1 receptor antagonist ezlopitant (CJ-11,974) against acute and delayed cisplatin-induced emesis in the ferretMegumi Tsuchiya, Yoshiko Fujiwara, Yoshihito Kanai, et al.

Journal of Medicinal Chemistry|January 19, 2007

SAR of a series of 5,6-dihydro-(9H)-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-alpha]pyridines as potent inhibitors of human eosinophil phosphodiesteraseAllen J Duplantier, Elizabeth L Bachert, John B Cheng, et al.

Pageof 1